Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci
- PMID: 14638510
- PMCID: PMC296177
- DOI: 10.1128/AAC.47.12.3964-3966.2003
Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci
Abstract
Penetration of linezolid into bone and joint tissues was studied by high-performance liquid chromatography in 13 patients suffering from implant-associated infections with methicillin-resistant staphylococci. Mean concentrations of linezolid in infected tissues were greater than 10 mg/liter in a sampling time range of 35 to 124 min after administration of the preoperative dose, except in bone specimens, where they reached 3.9 +/- 2.0 mg/liter.
Similar articles
-
Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.Eur J Clin Pharmacol. 2008 Nov;64(11):1093-100. doi: 10.1007/s00228-008-0531-5. Epub 2008 Jul 25. Eur J Clin Pharmacol. 2008. PMID: 18654767
-
Use of linezolid in children.Pediatr Infect Dis J. 2002 Sep;21(9):870-2. doi: 10.1097/00006454-200209000-00018. Pediatr Infect Dis J. 2002. PMID: 12352813 Review. No abstract available.
-
Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.Antimicrob Agents Chemother. 2003 Dec;47(12):3789-94. doi: 10.1128/AAC.47.12.3789-3794.2003. Antimicrob Agents Chemother. 2003. PMID: 14638484 Free PMC article. Clinical Trial.
-
Haematological safety of long-term therapy with linezolid.Int J Antimicrob Agents. 2007 Apr;29(4):480-3. doi: 10.1016/j.ijantimicag.2006.12.007. Epub 2007 Feb 20. Int J Antimicrob Agents. 2007. PMID: 17317112 Clinical Trial. No abstract available.
-
[Linezolid for pediatric infections].Arch Pediatr. 2010 Jun;17(6):762-3. doi: 10.1016/S0929-693X(10)70098-1. Arch Pediatr. 2010. PMID: 20654880 Review. French. No abstract available.
Cited by
-
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.Antimicrob Agents Chemother. 2005 Jun;49(6):2260-6. doi: 10.1128/AAC.49.6.2260-2266.2005. Antimicrob Agents Chemother. 2005. PMID: 15917519 Free PMC article. Clinical Trial.
-
Osteointegration of poly(L: -lactic acid)PLLA and poly(L: -lactic acid)PLLA/poly(ethylene oxide)PEO implants in rat tibiae.J Mater Sci Mater Med. 2008 Jul;19(7):2699-704. doi: 10.1007/s10856-008-3397-2. Epub 2008 Feb 19. J Mater Sci Mater Med. 2008. PMID: 18283533
-
Community-associated methicillin-resistant Staphylococcus aureus: incidence, clinical presentation, and treatment decisions.Curr Infect Dis Rep. 2007 Sep;9(5):391-7. doi: 10.1007/s11908-007-0061-9. Curr Infect Dis Rep. 2007. PMID: 17880850
-
Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.Antimicrob Agents Chemother. 2006 Jul;50(7):2455-63. doi: 10.1128/AAC.01468-05. Antimicrob Agents Chemother. 2006. PMID: 16801426 Free PMC article.
-
Systemic antibiotic therapy for chronic osteomyelitis in adults.Clin Infect Dis. 2012 Feb 1;54(3):393-407. doi: 10.1093/cid/cir842. Epub 2011 Dec 12. Clin Infect Dis. 2012. PMID: 22157324 Free PMC article. Review.
References
-
- Batts, D. H. 2000. Linezolid—a new option for treating gram-positive infections. Oncology (Huntington) 14:23-29. - PubMed
-
- Borner, K., E. Borner, and H. Lode. 2001. Determination of linezolid in human serum and urine by high-performance liquid chromatography. Int. J. Antimicrob. Agents 18:253-258. - PubMed
-
- Lovering, A. M., J. Zhang, G. C. Bannister, B. J. Lankester, J. H. Brown, G. Narendra, and A. P. MacGowan. 2002. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J. Antimicrob. Chemother. 50:73-77. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical